China, Nigeria Drugmakers Plan to Build Plant in African Nation
- Partners plan to start building the plant with 30 months
- Nigerian producers boost capacity as multinationals exit
This article is for subscribers only.
Nigeria’s biggest drugmaker will partner with Chinese firms to build a $100 million plant in the West African nation to help alleviate a shortage of medicines.
Fidson Healthcare Plc signed a cooperation memorandum with Jiangsu Aidea Pharmaceutical Co., PharmaBlock Sciences Nanjing Inc. and the China-Africa Development Fund to start building the facility in the commercial capital of Lagos within the next 30 months, the Nigerian drugmaker said by email.